Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testingHeidi J. Gray, Carla Grandori, Maddy Pollastro et al.|npj Precision Oncology|2023Cited by 26
Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2–Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid CorrelatesDaniel A. King, Calvin J. Kuo, Amber R. Smith et al.|JCO Precision Oncology|2023Cited by 15
Abstract PS4-01: Clinical and genomic correlation of a CLIA certified organoid based functional test in breast cancer patientsAstrid Margossian, Carla Grandori, Anne Richardson et al.|Cancer Research|2021Cited by 1
Complete remission in a patient with widely metastatic HER2-amplified pancreatic adenocarcinoma following multimodal therapy informed by tumor sequencing and organoid profilingDaniel A. King, Calvin J. Kuo, Amber R. Smith et al.|medRxiv|2021Cited by 1